Comments on Rapamycin and Metformin
Posted: May 12, 2013 at 3:05 am
Three of the better known efforts to create a drug that modestly slows the rate of aging are centered on the following items:
- Resveratrol analogs that target sirtuins
- Rapamycin analogs that target mTOR
- Metformin
Of these, ways to manipulate the activity of sirtuins have received the greatest attention over the past decade, but there is little to show for all that money and time beyond a modest gain in the understanding of metabolism. There are no replicated, solid results of life extension in mice via sirtuin-influencing drugs, and I'd go so far as to say that the field is under something of a cloud at present. Metformin is in a similar position: while a large body of work relates to its use as a treatment for type 2 diabetes, the evidence for its ability to extend life in laboratory animals is mixed at best. Rapamycin is the only one of the three that can boast solid, replicated evidence of life extension in mice. It is a drug that has been in use as an immunosuppressant for more than a decade, but its ability to extend life is a more recent finding.
For today I thought I'd point out a couple of open access items containing recent findings on the use of rapamycin and metformin in the context of aging. While I don't believe that this branch of research is particularly relevant to extending human life by any meaningful amount in the near term, it is interesting to watch and may help to shed more light on the relative importance of various aspects of our biology in aging. The metformin paper in particular is an educational attempt to tie in the senescent cell aspect of aging to study results:
Metformin, a widely used antidiabetic drug, has been linked to a reduced cancer incidence in some retrospective, hypothesis-generating studies. What is the mechanism by which aging may increase cancer incidence? Although many molecular changes correlate with aging, the presence of senescent cells capable of secreting inflammatory cytokines may be involved. This senescence associated secretory phenotype (SASP) consists of multiple cytokines, chemokines, growth factors and extracellular matrix degrading enzymes that can potentially affect normal tissue structure.
The SASP probably evolved as a gene expression program to assist the senescent tumor suppression response and tissue repair after damage and should be viewed as an initial adaptive response. However, [chronic] SASP [like chronic inflammation] may cause a microenvironment in old tissues that facilitates tumor initiation and then stimulates cancer cell growth.
This unfortunate interaction between senescent cells and cancer cells has been reproduced in experimental mouse models where senescent fibroblasts stimulated tumor progression. [During] experiments to study the potential cancer prevention activity of metformin, we found serendipitously that the drug prevented the expression of many proteases, cytokines and chemokines in senescent cells. We thus propose that metformin prevents cancer by modulating the SASP in tissues where senescent cells were not naturally cleared.
Prolonged Rapamycin treatment led to beneficial metabolic switch
In the first robust demonstration of pharmacologically-induced life extension in a mammal, rapamycin increased longevity of mice via either feeding or injection. However, rapamycin treatment also showed the detrimental metabolic effects, including hyperinsulinemia, hyperlipidemia, glucose intolerance and insulin resistance. Those observations present a paradox of improved survival despite metabolic impairments. How rapamycin extended lifespan with such paradoxical metabolic effects remains to be elucidated.
In the various studies of rapamycin treatment, length of rapamycin treatment varied from two weeks to two years. With short-term rapamycin treatment, mice showed the detrimental metabolic effects, while a much longer length (up to 1.5 to 2 years) of rapamycin treatment led to increased longevity. Duration of rapamycin treatment may be one of the key factors that determine outcomes of the treatment. Longer-term rapamycin treatment may cause beneficial metabolic "switch" that is associated with enhanced insulin signaling and extended longevity.
We [recently] reported that duration of rapamycin treatment indeed has differential effects on metabolism. In our study, rapamycin was given to mice for two, six or 20 weeks. Consistently with the previous reports, mice with two weeks of rapamycin treatment had characteristics of metabolic syndrome. Mice with six weeks of rapamycin treatment were in the metabolic transition status. When rapamycin treatment continued for 20 weeks, the detrimental metabolic effects were reversed or diminished.
It's worth taking some time to look over the state of research for these front-runners in the old-school drug discovery approach to extending life. I find it serves well as a way to inoculate yourself against unfounded optimism and unreasonable expectations, both now and the next time that both the "anti-aging" marketplace and biotech startups tout something that you can buy to supposedly influence metabolism and aging. If you have an enthusiasm for living longer, better to channel it into exercise, calorie restriction, and fundraising for the SENS Research Foundation.
Source:
http://www.fightaging.org/archives/2013/05/comments-on-rapamycin-and-metformin.php
- Grand Traverse Co. Health Department Seeks Volunteers for Hagerty Center Vaccination Clinics - 9&10 News - January 20th, 2021
- How to live longer: Should you skip breakfast to promote longevity? Doctor weighs in - Express - December 28th, 2020
- China Long Avoided Talking About Mental Health. Then Covid Hit. - The New York Times - December 22nd, 2020
- With fitness centers shut down due to COVID-19, home gyms are on the rise - SW News Media - December 10th, 2020
- Review: Equinox Takes Luxe Fitness Into The Wild at Their First Outdoor Gym in LA - InsideHook - September 30th, 2020
- Colorados fitness industry starting to reawaken, but some studios will never reopen - Loveland Reporter-Herald - June 16th, 2020
- In sickness and in health: North Spokane couple weds in front yard during pandemic - The Spokesman-Review - May 18th, 2020
- Furry Friends Provide Big Benefits - June 20th, 2018
- CT Nutrition Consultants - Registered Dietitian - July 12th, 2017
- Channel Update - Fitness & Football Videos Only! - Video - August 10th, 2014
- Measuring the Impact of Cytomegalovirus in Younger People - September 1st, 2013
- Decreased mTOR Expression Provides 20% Mean Life Span Extension in Mice - September 1st, 2013
- A Collagen Patch to Spur Heart Tissue Repair - September 1st, 2013
- Statin Use Correlates With Higher Telomerase Activity - September 1st, 2013
- Children of Long-Lived Parents Have Better Immune Systems - September 1st, 2013
- A Two-Part Report on Global Futures 2045 - August 25th, 2013
- The Next Few Years of Research Into Alzheimer's Disease - August 25th, 2013
- A Look Back at Some of the Roots of Modern Thought on Radical Life Extension - August 25th, 2013
- Damaging the Biology of Mice to Make them Age More Rapidly Often Tells Us Little of Use - August 25th, 2013
- Calorie Restriction as a Means to Augment Cancer Therapies - August 25th, 2013
- Life Without Ageing: Aubrey de Grey and Tom Kirkwood to Debate Longevity Science at the British Science Festival - August 18th, 2013
- A Short Overview of 3-D Printing in Tissue Engineering - August 18th, 2013
- Another Way to Improve Memory in Old Mice - August 18th, 2013
- SENS Research Foundation Releases 2013 Research Report - August 18th, 2013
- Targeting Redox Biology to Reverse Mitochondrial Dysfunction - August 18th, 2013
- The Cost of Living Longer, Even in Good Health - August 11th, 2013
- Signs of Progress: Insurers Talk of Radical Life Extension - August 11th, 2013
- The Current State of Knowledge of Genetics and Longevity - August 11th, 2013
- A Video Tour of Alcor and Interview With Max More - August 11th, 2013
- And Now For Something Reprehensible - August 11th, 2013
- Opposing the Argument that Increased Longevity Will Slow Progress, and is Therefore Undesirable - August 4th, 2013
- Considering State Opposition to Life Extension Technologies - August 4th, 2013
- Steps Towards a Tissue Engineered Thymus - August 4th, 2013
- The Intersection of Kickstarter-Style Fundraising for Research and Distributed Development in Complex Problems - August 4th, 2013
- The Cost of Being Tall is a Shorter Life Expectancy - August 4th, 2013
- A Little Methionine Restriction Research - June 16th, 2013
- Calorie Restriction Versus Resveratrol Treatment - June 16th, 2013
- Reviewing the Literature on Calorie Restriction and Oxidative Stress - June 16th, 2013
- Arguing By Induction For an Absence of Boredom in an Ageless, Greatly Extended Healthy Life - June 16th, 2013
- Investigating Fingertip Regeneration in Mammals - June 16th, 2013
- The Incentives Associated With Becoming a Machine Entity - June 9th, 2013
- A Good Scientific Polemic on Aging - June 9th, 2013
- Quantifying Neurogenesis in Adult Humans - June 9th, 2013
- Considering the Details of Replacing the Brain - June 9th, 2013
- Overreacting in the Direction of Doing Nothing - June 9th, 2013
- Considering the Regenerative Signals Emitted by Transplanted Stem Cells - June 2nd, 2013
- A Bioprosthetic Heart - June 2nd, 2013
- Exercise Versus Peripheral Artery Disease - June 2nd, 2013
- Bracketed by Billionaires - June 2nd, 2013
- Stem Cell Transplants for Leukemia Showing Improved Outcomes - June 2nd, 2013
- Videos from the SENS Research Foundation Evidence Studios Event in December 2012 - May 26th, 2013
- Early Mortality Rates Predict Late Mortality Rates - May 26th, 2013
- Decellularization May Enable Use of More Donor Organs - May 26th, 2013
- Mitochondrially Targeted Antioxidant SS-31 Reverses Some Measures of Aging in Muscle - May 26th, 2013
- Arguing for the Role of Nuclear DNA Damage in Aging - May 26th, 2013
- Reviewing the Results of Calorie Restriction Primate Studies - May 19th, 2013
- A Possible Biomarker for Senescent Cells - May 19th, 2013
- Inhibiting ICMT as a Progeria Therapy - May 19th, 2013
- Are the Most Influential Futurists Those Who Put in the Work to Make Their Visions Real? - May 19th, 2013
- Excess Body Fat Hardens Arteries - May 19th, 2013
- The Present State of Artificial Retinas - May 12th, 2013
- The State of Electromechanical and Bioartifical Organs - May 12th, 2013
- Parabiosis Points to GDF-11 as a Means to Reverse Age-Related Cardiac Hypertrophy - May 12th, 2013
- Insights into Inflammaging - May 12th, 2013
- A Different Take on NF-?B and the Hypothalamus - May 5th, 2013
- T-Regulatory Cells More Numerous in the Aged Immune System - May 5th, 2013
- HMGA1 as a Potential Common Mechanism in Cancer - May 5th, 2013
- Recent Research Results from the Study of Naked Mole Rats - May 5th, 2013
- A Skeptical View of Mitochondrial DNA Damage and Aging - May 5th, 2013
- Recent Calorie Restriction Research - April 28th, 2013
- Joining the Dots in Genetic Parkinson's Disease - April 28th, 2013
- Considering the Electron Transport Chain in Aging - April 28th, 2013
- More Data on Granulocyte Transplant Cancer Therapies - April 28th, 2013
- Measures of Mitochondrial DNA Damage Lower in Long-Lived Mice - April 28th, 2013
- Aubrey de Grey on "The Undoing of Aging" - April 21st, 2013
- Mitochondrial Functional Mutations and Worm Longevity - April 21st, 2013
- Indy Mutations and Fly Longevity - April 21st, 2013
- Further Research on BubR1, Cellular Senescence, and Aging - April 21st, 2013
- Sterilized Dogs Live Longer - April 21st, 2013
- Robust Cancer Therapies Will Mean a Greater Use of Aggressive Stem Cell Therapies - April 14th, 2013